Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer

Molecular Cell

Volumn 12, Issue 5, 2003, Pages 1239-1250

  Seubert, Nadine ^a,b   Royer, Yohan ^a,b   Staerk, Judith ^a,b   Kubatzky, Katharina F ^a,b   Moucadel, Virginie ^a,b   Krishnakumar, Shyam ^c   Smith, Steven O ^c   Constantinescu, Stefan N ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMERIC IONIC CONTRAST MEDIUM; ERYTHROPOIETIN RECEPTOR; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONFORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; MOUSE; NONHUMAN; ORIENTATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0344413478     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00389-7     Document Type: Article

References (47)

1. Adamian L., Liang J. Interhelical hydrogen bonds and spatial motifs in membrane proteins. polar clamps and serine zippers Proteins. 47:2002;209-218.
2. Adams P.D., Engelman D.M., Brunger A.T. Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching. Proteins. 26:1996;257-261.
3. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
4. Bergelson S., Klingmuller U., Socolovsky M., Hsiao J.G., Lodish H.F. Tyrosine residues within the intracellular domain of the erythropoietin receptor mediate activation of AP-1 transcription factors. J. Biol. Chem. 273:1998;2396-2401.
5. Carroll M.P., Spivak J.L., McMahon M., Weich N., Rapp U.R., May W.S. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Chem. 266:1991;14964-14969.
6. Cochran A.G., Kim P.S. Imitation of Escherichia coli aspartate receptor signaling in engineered dimers of the cytoplasmic domain. Science. 271:1996;1113-1116.
7. Constantinescu S.N., Ghaffari S., Lodish H.F. The erythropoietin receptor. structure, activation and intracellular signal transduction Trends Endocrinol. Metab. 10:1999;18-23. a.
8. Constantinescu S.N., Liu X., Beyer W., Fallon A., Shekar S., Henis Y.I., Smith S.O., Lodish H.F. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain. EMBO J. 18:1999;3334-3347. b.
9. Constantinescu S.N., Huang L.J., Nam H., Lodish H.F. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented motif. Mol. Cell. 7:2001;377-385. a.
10. Constantinescu S.N., Keren T., Socolovsky M., Nam H., Henis Y.I., Lodish H.F. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc. Natl. Acad. Sci. USA. 98:2001;4379-4384. b.
11. Damen J.E., Cutler R.L., Jiao H., Yi T., Krystal G. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 270:1995;23402-23408. a.
12. Damen J.E., Wakao H., Miyajima A., Krosl J., Humphries R.K., Cutler R.L., Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:1995;5557-5568. b.
13. D'Andrea A.D., Lodish H.F., Wong G.G. Expression cloning of the murine erythropoietin receptor. Cell. 57:1989;277-285.
14. Darnell J.E., Kerr I.M., Stark G. Jak-STAT pathways and transcriptional activation in response to ifn's and other extracellular signaling proteins. Science. 264:1994;1415-1420.
15. Dawson J.P., Weinger J.S., Engelman D.M. Motifs of serine and threonine can drive association of transmembrane helices. J. Mol. Biol. 316:2002;799-805.
16. Eilers M., Patel A.B., Liu W., Smith S.O. Comparison of helix interactions in membrane and soluble alpha-bundle proteins. Biophys. J. 82:2002;2720-2736.
17. Elliott S., Lorenzini T., Yanagihara D., Chang D., Elliott G. Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies. J. Biol. Chem. 271:1996;24691-24697.
18. Eyckerman S., Waelput W., Verhee A., Broekaert D., Vandekerckhove J., Tavernier J. Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line. Eur. Cytokine Netw. 10:1999;549-556.
19. Gobert S., Duprez V., Lacombe C., Gisselbrecht S., Mayeux P. The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells. Eur. J. Biochem. 234:1995;75-83.
20. Gobert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I., Groner B., Lacombe C., Gisselbrecht S., Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15:1996;2434-2441.
21. Gurezka R., Laage R., Brosig B., Langosch D. A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments. J. Biol. Chem. 274:1999;9265-9270.
22. Hoatlin M.E., Ferro F. Jr., Geib R.W., Fox M.T., Kozak S.L., Kabat D. Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia. J. Virol. 69:1995;856-863.
23. Huang L.J., Constantinescu S.N., Lodish H.F. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol. Cell. 8:2001;1327-1338.
24. Ihle J.N. The Stat family in cytokine signaling. Curr. Opin. Cell Biol. 13:2001;211-217.
25. Kirito K., Nakajima K., Watanabe T., Uchida M., Tanaka M., Ozawa K., Komatsu N. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood. 99:2002;102-110.
26. Klingmuller U., Bergelson S., Hsiao J.G., Lodish H.F. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc. Natl. Acad. Sci. USA. 93:1996;8324-8328.
27. Klingmuller U., Wu H., Hsiao J.G., Toker A., Duckworth B.C., Cantley L.C., Lodish H.F. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA. 94:1997;3016-3021.
28. Kubatzky K.F., Ruan W., Gurezka R., Cohen J., Ketteler R., Watowich S.S., Neumann D., Langosch D., Klingmuller U. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor. Curr. Biol. 11:2001;110-115.
29. Li J.-P., D'Andrea A.D., Lodish H.F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature. 343:1990;762-764.
30. Liu X., Constantinescu S.N., Sun Y., Bogan J.S., Hirsch D., Weinberg R.A., Lodish H.F. Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal. Biochem. 280:2000;20-28.
31. Livnah O., Johnson D.L., Stura E.A., Farrell F.X., Barbone F.P., You Y., Liu K.D., Goldsmith M.A., He W., Krause C.D., et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat. Struct. Biol. 5:1998;993-1004.
32. Livnah O., Stura E.A., Johnson D.L., Middleton S.A., Mulcahy L.S., Wrighton N.C., Dower W.J., Jolliffe L.K., Wilson I.A. Functional mimicry of a protein hormone by a peptide agonist. the EPO receptor complex at 2.8 Å Science. 273:1996;464-471.
33. Livnah O., Stura E.A., Middleton S.A., Johnson D.L., Jolliffe L.K., Wilson I.A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 283:1999;987-990.
34. Mattoon D., Gupta K., Doyon J., Loll P.J., DiMaio D. Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein. Oncogene. 20:2001;3824-3834.
35. Miura Y., Miura O., Ihle J.N., Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269:1994;29962-29969.
36. Palacios R., Steinmetz M. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 41:1985;727-734.
37. Sotiropoulos A., Moutoussamy S., Renaudie F., Clauss M., Kayser C., Gouilleux F., Kelly P.A., Finidori J. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 10:1996;998-1009.
38. Storz P., Doppler H., Horn-Muller J., Groner B., Pfizenmaier K., Muller G. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression. Anal. Biochem. 276:1999;97-104.
39. Swaminathan K., Flynn P., Reece R.J., Marmorstein R. Crystal structure of a PUT3-DNA complex reveals a novel mechanism for DNA recognition by a protein containing a Zn2Cys6 binuclear cluster. Nat. Struct. Biol. 4:1997;751-759.
40. Syed R.S., Reid S.W., Li C., Cheetham J.C., Aoki K.H., Liu B., Zhan H., Osslund T.D., Chirino A.J., Zhang J., et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 395:1998;511-516.
41. Treisman R. Journey to the surface of the cell. Fos regulation and the SRE EMBO J. 14:1995;4905-4913.
42. Wakao H., Harada N., Kitamura T., Mui A., Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J. 14:1995;2527-2535.
43. Walters K.J., Dayie K.T., Reece R.J., Ptashne M., Wagner G. Structure and mobility of the PUT3 dimer. Nat. Struct. Biol. 4:1997;744-750.
44. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-236.
45. Wrighton N.C., Farrell F.X., Chang R., Kashyap A.K., Barbone F.P., Mulcahy L.S., Johnson D.L., Barrett R.W., Jolliffe L.K., Dower W.J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 273:1996;458-464.
46. Wu H., Liu X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:1995;59-67.
47. Yoshimura A., Longmore G., Lodish H.F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 348:1990;647-649.